IBM (IBM) vs Lululemon (LULU)
| IBM | (dif) | Lululemon | |
|---|---|---|---|
| Market Cap | $198.4 billion | $-160.6 billion | $37.9 billion |
| Shares Outstanding | 924.6 million | -807.0 million | 117.7 million |
| Revenue | $62.6 billion | $-52.6 billion | $10.0 billion |
| Revenue Per Share | $68.11 | $11.27 | $79.37 |
| Insiders Ownership | 0.12% | 4.51% | 4.63% |
| Net Income | $6.4 billion | $-4.7 billion | $1.6 billion |
| Profit Margins | 10.22% | 6.12% | 16.34% |
| Cash | $13.7 billion | $-12.1 billion | $1.6 billion |
| Debt | $60.1 billion | $-58.7 billion | $1.5 billion |
Discover which stock is a better investment
© 2024 MyWallSt Ltd. All rights reserved. This website is operated by MyWallSt Ltd (“MyWallSt”). MyWallSt is a publisher and a technology platform, not a registered broker-dealer or registered investment adviser, and does not provide investment advice. All information provided by MyWallSt Limited is of a general nature for information and education purposes, and you should not construe any such information as investment advice. MyWallSt Limited does not take your specific needs, investment objectives or financial situation into consideration, and any investments mentioned may not be suitable for you. You should always carry out your own independent verification of facts and data before making any investment decisions, as we cannot guarantee the accuracy or completeness of any information we publish and any opinions that we publish may be wrong and may change at any time without notice. If you are unsure of any investment decision you should seek a professional financial advisor. MyWallSt Limited is not a registered investment adviser and we do not provide regulated investment advice or recommendations. MyWallSt Limited is not regulated by the Central Bank of Ireland. MyWallSt Limited may provide hyperlinks to web sites operated by third parties. Your use of third party web sites and content, including without limitation, your use of any information, data, advertising, products, or other materials on or available through such web sites, is at your own risk and is subject to the third parties’ terms of use.